PH25857A - 3-substituted-2-oxindole-1-carboxamides for suppressing T-cell function - Google Patents

3-substituted-2-oxindole-1-carboxamides for suppressing T-cell function

Info

Publication number
PH25857A
PH25857A PH38415A PH38415A PH25857A PH 25857 A PH25857 A PH 25857A PH 38415 A PH38415 A PH 38415A PH 38415 A PH38415 A PH 38415A PH 25857 A PH25857 A PH 25857A
Authority
PH
Philippines
Prior art keywords
cell function
oxindole
carboxamides
substituted
suppressing
Prior art date
Application number
PH38415A
Other languages
English (en)
Inventor
Henry James Showell
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of PH25857A publication Critical patent/PH25857A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Peptides Or Proteins (AREA)
PH38415A 1988-04-13 1989-03-31 3-substituted-2-oxindole-1-carboxamides for suppressing T-cell function PH25857A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/181,142 US4853409A (en) 1988-04-13 1988-04-13 3-substituted-2-oxindole-1-carboxamides for suppressing T-cell function

Publications (1)

Publication Number Publication Date
PH25857A true PH25857A (en) 1991-12-02

Family

ID=22663072

Family Applications (1)

Application Number Title Priority Date Filing Date
PH38415A PH25857A (en) 1988-04-13 1989-03-31 3-substituted-2-oxindole-1-carboxamides for suppressing T-cell function

Country Status (17)

Country Link
US (1) US4853409A (de)
EP (1) EP0337628B1 (de)
JP (1) JPH01311022A (de)
KR (1) KR920002328B1 (de)
AT (1) ATE89725T1 (de)
AU (1) AU601326B2 (de)
CA (1) CA1324762C (de)
DE (1) DE68906707T2 (de)
DK (1) DK174289A (de)
HU (1) HU204996B (de)
IE (1) IE62751B1 (de)
IL (1) IL89872A (de)
MY (1) MY103872A (de)
NZ (1) NZ228712A (de)
PH (1) PH25857A (de)
PT (1) PT90249B (de)
ZA (1) ZA892622B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5008283A (en) * 1990-03-19 1991-04-16 Pfizer Inc. Use of tenidap to inhibit activation of collagenase and to inhibit the activity of myeloperoxidase
US5006547A (en) * 1990-03-19 1991-04-09 Pfizer Inc. Tenidap as an inhibitor of the release of elastase by neutrophils
US5122534A (en) * 1991-02-08 1992-06-16 Pfizer Inc. Use of tenidap to reduce total serum cholesterol, ldl cholesterol and triglycerides
DE4111306C2 (de) * 1991-04-08 1994-06-01 Mack Chem Pharm Pharmazeutische Zubereitungen, die ein 2-Oxindol-l-carboxamid-derivat enthalten und zur Injektion bestimmt sind
DE4111305C2 (de) * 1991-04-08 1994-12-01 Mack Chem Pharm Pharmazeutische Zubereitung zur rektalen Applikation, die ein 2-Oxindol-l-carboxamid-derivat enthält
US5298522A (en) * 1993-01-22 1994-03-29 Pfizer Inc. 6-chloro-5-fluoro-3-(2-thenoyl)-2-oxindole-1-carboxamide as an analgesic and anti-inflammatory agent while maintaining a normal urine protein/creatinine ratio
CN1116822A (zh) * 1993-01-22 1996-02-14 美国辉瑞有限公司 6-氯-5-氟-3-(2-噻吩甲酰)-2-羟吲哚-1-羰酰胺的赖氨酸盐
US5545656A (en) * 1995-04-05 1996-08-13 Pfizer Inc. 2-Oxidole-1-carboxamide pharmaceutical agents for the treatment of alzheimer's disease
BG62359B1 (bg) * 1995-07-13 1999-09-30 Anormed N,n-диетил-8,8-дипропил-2-азаспиро[4,5]декан-2-пропанаминдималеат
WO1997022605A1 (en) * 1995-12-19 1997-06-26 Pfizer Inc. Stable, long acting salts of indole derivatives for the treatment of joint diseases
EP0826685A1 (de) * 1996-08-21 1998-03-04 Pfizer Inc. Stabile, lange aktive Salze von Carboxamiden für die Behandlung von Gelenkskrankheiten
WO2006105796A1 (en) * 2005-04-08 2006-10-12 Leo Pharma A/S Novel indolinone derivatives
EP2886541A1 (de) * 2013-12-19 2015-06-24 Sanofi Oxindolderivate, ihre Herstellung und ihre therapeutische Verwendung zur Behandlung von durch AMPK vermittelten Erkrankungen

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4556672A (en) * 1984-03-19 1985-12-03 Pfizer Inc. 3-Substituted 2-oxindole-1-carboxamides as analgesic and anti-inflammatory agents
DE3413572A1 (de) * 1984-04-11 1985-10-24 Hoechst Ag, 6230 Frankfurt Oxindol-verbindungen zur behandlung der epilepsie
US4569942A (en) * 1984-05-04 1986-02-11 Pfizer Inc. N,3-Disubstituted 2-oxindole-1-carboxamides as analgesic and antiinflammatory agents
AU6898287A (en) * 1986-01-30 1987-08-25 University Of Utah, The Treatment of bone loss
RO105052B1 (en) * 1987-02-02 1994-12-01 Pfizer Producing process for the crystalline sodium salt, anhydre, of 5-chlorine-3-(2-tenoil)-2-oxindol-1-carboxamide

Also Published As

Publication number Publication date
EP0337628B1 (de) 1993-05-26
ZA892622B (en) 1990-11-28
JPH01311022A (ja) 1989-12-15
EP0337628A3 (de) 1991-01-02
NZ228712A (en) 1997-02-24
IE891171L (en) 1989-10-13
PT90249B (pt) 1994-06-30
AU3271289A (en) 1989-10-19
MY103872A (en) 1993-09-30
HUT52376A (en) 1990-07-28
US4853409A (en) 1989-08-01
AU601326B2 (en) 1990-09-06
DK174289A (da) 1989-10-16
EP0337628A2 (de) 1989-10-18
KR920002328B1 (ko) 1992-03-21
ATE89725T1 (de) 1993-06-15
IL89872A0 (en) 1989-12-15
KR890015740A (ko) 1989-11-25
IL89872A (en) 1994-06-24
CA1324762C (en) 1993-11-30
DK174289D0 (da) 1989-04-12
PT90249A (pt) 1989-11-10
IE62751B1 (en) 1995-02-22
HU204996B (en) 1992-03-30
DE68906707T2 (de) 1993-09-16
DE68906707D1 (de) 1993-07-01

Similar Documents

Publication Publication Date Title
ZA892622B (en) 3-substituted-2-oxindole-1-carboxamides for suppressing t-cell function
PH31263A (en) Methods of inhibiting vascular smooth muscle cell proliferation and restinosis.
EP0363415A4 (en) Compounds for the treatment of alzheimer's disease
CA2029420A1 (en) Pharmaceutical compositions and methods for inhibition of maillard's reaction
IL87421A (en) Pharmaceutical compositions containing 5-amino (or substituted amino) - 1,2,3-triazoles
ZA88385B (en) Novel naphthalene derivatives having use as antiallergy and antiinflammatory agents
ATE89724T1 (de) 3-substituierte 2-oxindol-1-carboxamid-derivate als hemmer der biosynthese des interleukins-1.
EP0334685A3 (de) Analoge von Bradykinin, dessen Synthese und dessen Benutzung in der Therapie
GR3025518T3 (en) Use of the N-n-butyl derivative of desoxynojirimycin in the manufacture of a medicament inhibiting HIV-Virus
FI891473A (fi) Menetelmä terapeuttisesti käyttökelpoisten 4-aryyli-4-piperidiinikarbinolien valmistamiseksi
IL78954A0 (en) Spiro-imidazolidines and pharmaceutical compositions containing them
ES2081834T3 (es) Pirrolidin-2-onas 4-metil y 4-etil sustituidas.
IL92867A0 (en) N-pyridinyl-9h-carbazol-9-amines,a process for their preparation and their use as medicaments
FR2584073B1 (fr) Analogues d'amino-prostaglandines a substituant 5,6-epoxy-7-oxabicycloheptane, utilisables pour le traitement des thromboses
DE3887426D1 (de) Eperisone als Hypotonikum.
IL98200A0 (en) Pharmaceutical composition containing a derivative of substituted-l-valyl-l-prolinamide
GB2201343B (en) Ponalrestat as a hypouricaemic agent
ATE111462T1 (de) 1,4-dihydropyridin-derivate.
RU93052163A (ru) (s) - (+) - гидроксихлорохин и композиция для лечения
IT8024828A0 (it) Impiego dell'alfa-chetoglutarato di piridossina nella terapia della iperlattacidemia.